Understanding MAT Access in the Context of Unused MAT Capacity in the United States: When Increasing Rural MAT Capacity is Not Enough

View Resource

Examines the factors related to buprenorphine prescriptions to treat opioid use disorder (OUD) and the impacts of the federal DATA waiver to increase provider capacity. Utilizes multiple data sources to describe medication-assisted treatment (MAT) capacity, access, barriers, availability of MAT, and service area need in rural areas.

Carolyn Carpenedo Mun, Rachel Zambrano, Eileen Tallman, et al.

Substance Abuse Treatment, Prevention, and Policy, 19, 47

12/2024

Document

Access · Illicit drug use · Legislation and regulations · Pharmacy and prescription drugs · Prescription drug misuse · Specialty care · Statistics and data